Rhesus (Rh) Antibody Screening Test

The Rhesus (Rh) Antibody Screening Test at Pamel Laboratories is a critical blood test used to detect the presence of antibodies against Rh-positive red blood cells in individuals who are Rh-negative. This test is especially important during pregnancy, as Rh incompatibility between a mother and her unborn baby can lead to hemolytic disease of the newborn (HDN) — a potentially life-threatening condition.

By identifying Rh antibodies early, healthcare providers can take preventive measures to protect both mother and child.

Purpose of the Test:

• Detect Rh antibodies in Rh-negative individuals

• Assess risk of Rh incompatibility during pregnancy

• Prevent hemolytic disease in newborns

• Monitor women with a history of Rh sensitization

• Evaluate candidates for blood transfusion or organ transplant

Who Should Take This Test:

• Pregnant women who are Rh-negative

• Rh-negative individuals who have had previous transfusions or miscarriages

• Women with a history of HDN in prior pregnancies

Sample Type: Venous blood

Turnaround Time: 24–48 hours

Test Method: Indirect Antiglobulin Test (Indirect Coombs Test)

Result Interpretation:

• Negative: No Rh antibodies detected (no sensitization)

• Positive: Rh antibodies detected — further monitoring or treatment required

Why Choose Pamel Laboratories?

• Reliable and sensitive antibody detection

• Ideal for prenatal care and transfusion safety

• Expert laboratory scientists and quick reporting

Protect your pregnancy and health with early detection. Book your Rhesus Antibody Screening Test today at Pamel Laboratories — trusted care for you and your baby.